Advertisement
Advertisement

KRON

KRON logo

Kronos Bio Inc

0.9537
USD
-0.0026
-0.27%
Dec 18, 15:50 UTC -5
Closed
...

Kronos Bio Inc Profile

About

Kronos Bio Inc. is a clinical-stage biopharmaceutical company. It engages in discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. Kronos Bio Inc. is headquartered in San Mateo, Calif.

Info & Links

CEO

Norbert Bischofberger

Headquarters

1300 S. EL CAMINO REAL, SUITE 400
SAN MATEO, CA 94402, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

46

Employees

63

Kronos Bio Inc Statistics

Valuation Measures

Market Capitalization2

57.55M

Enterprise Value

-17.42M

Enterprise Value/EBITDA(ttm)

0.19

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.99

Price to Book(mrq)

0.53

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-867.66%

Profit Margin(ttm)

-873.59%

Return on Equity(ttm)

-64.55%

Return on Invested Capital(ttm)

-63.64%

Return on Assets(ttm)

-48.18%

Income Statement

Revenue(ttm)

9.86M

Revenue Per Share(ttm)

0.16

Gross Profit(ttm)

9.86M

EBITDA(ttm)3

-92.05M

Net Income Available to Common(ttm)

-85.59M

Diluted EPS(ttm)

-1.43

Share Statistics

Beta (5Y Monthly)

1.83

52-Week Change

-19.18%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

60.34M

Dividend Yield

0.00%

Float4

45.62M

% Held by Insiders

24.40%

% Held by Institutions

64.09%

Balance Sheet

Total Cash(mrq)

124.86M

Total Cash Per Share(mrq)

2.07

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.32%

Quick Ratio(mrq)

8.32%

Book Value Per Share(mrq)

1.84

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.87

Free Cash Flow(ytd)

-52.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement